Administration of DAB389IL-2 to patients with recalcitrant psoriasis: a double-blind, phase II multicenter trial. - Bagel,J.; Garland,W.T.; Breneman,D.; Holick,M.; Littlejohn,T.W.; Crosby,D.; Faust,H.; Fivenson,D.; Nichols,J. (J Am Acad Dermatol, 1998)